Financhill
Back

Editas Medicine Vs. Direxion Daily S&P Biotech Bull 3X Shares Industry Stock Comparison

Sell
24

EDIT
Editas Medicine

Last Price:
$1.30
Seasonality Move:
2.34%
Sell
22

LABU
Direxion Daily S&P Biotech Bull 3X Shares

Last Price:
$44.19
Seasonality Move:
24.76%
Sell
24
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $1.30. The Score for EDIT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Direxion Daily S&P Biotech Bull 3X Shares (LABU) is a Sell

Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $44.14. The Score for LABU is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • LABU is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $1.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

LABU Stock Price Chart

What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?

  • The Direxion Daily S&P Biotech Bull 3X Shares share price today is $44.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABU is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 50.52 Buy
Chaikin Money Flow: 3132166 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.11 - 1.45) Buy
Bollinger Bands (100): (1.12 - 2.06) Sell

LABU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.44 Sell
Relative Strength Index (14 RSI): 34.94 Sell
Chaikin Money Flow: 2288232 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.25 - 79.03) Sell
Bollinger Bands (100): (69.52 - 109.38) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.11 Buy
20-day SMA: 1.22 Buy
50-day SMA: 1.45 Sell
200-day SMA: 2.81 Sell
8-day EMA: 1.13 Buy
20-day EMA: 0.95 Buy
50-day EMA: 0.58 Buy
200-day EMA: 0.19 Buy

LABU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46 Sell
20-day SMA: 61.78 Sell
50-day SMA: 76.25 Sell
200-day SMA: 109.08 Sell
8-day EMA: 47 Sell
20-day EMA: 57.74 Sell
50-day EMA: 72.23 Sell
200-day EMA: 98.73 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.

Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):